GW Pharmaceuticals Plc

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
HZNPHorizon Therapeutics Plc -0.26%93.275.5%$179.13m
VRXValeant Pharmaceuticals International, Inc. -0.86%30.0414.1%$176.76m
ICLRICON plc -0.36%204.474.2%$131.48m
CTLTCatalent, Inc. -0.40%110.552.1%$123.68m
GWPHGW Pharmaceuticals Plc 0.04%218.906.1%$117.99m
UTHRUnited Therapeutics Corp. 1.02%203.7314.1%$97.91m
JAZZJazz Pharmaceuticals Plc 0.30%168.902.3%$91.17m
BHCBausch Health Cos., Inc. -0.86%30.040.0%$90.58m
SAVACassava Sciences, Inc. -0.68%34.850.0%$53.32m
ARGXargenx SE 1.53%281.720.0%$51.68m
PRGOPerrigo Co. Plc 1.14%41.646.9%$37.87m
SAGESAGE Therapeutics, Inc. -1.14%74.647.6%$36.56m
PCRXPacira Biosciences, Inc. -4.93%63.079.9%$28.43m
AMRNAmarin Corp. Plc 0.20%5.021.5%$27.84m
ICPTIntercept Pharmaceuticals, Inc. -1.31%20.2816.8%$26.02m

Company Profile

GW Pharmaceuticals Plc operates as a biopharmaceutical company. The firm engages in the discovery, development and commercialization of novel therapeutics. It offers its cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.